on,adecreased appetite,cirritability,cheadache, somnolencec, myalgia, injection site pain, injection site erythema, malaise, asthenia, fever. Common (≥1/100 to <1/10): nasopharyngitis, pharyngotonsillitis,barthralgia, injection site swelling, injection site bruising,einjection site pruritus,einfluenza like illness.aIncludes upper respiratory tract infection and viral upper respiratory tract infection.bIncludes pharyngotonsillitis and tonsillitis.cCollected in children below 6 years of age in clinical studies.dIncludes rash, viral rash, rash maculopapular, and rash pruritic.eReported in adults in clinical studies.Refer to the SmPC for details on full side effect profile and interactions.

For full prescribing information, please see theSummary of Product Characteristics(SmPC) for QDENGA®▼.

Please consult with your local regulatory agency for any approved labeling in your country.

The drug information contained herein is intended to disclose corpora
=*=*=*=*=*=
当前为第11/21页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页